Drugs, sport and the Olympics 2000–2004

Michael C Kennedy

Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital, Darlinghurst, NSW 2010. drmkennATozemail.com.au

Correspondence: drmkenn@ozemail.com.au

1. The World Anti-Doping Code. Available at: www.wada-ama.org (accessed Jul 2004).
2. Stein J. Chasing the truth. Time 2004; June 7: 54-55.
3. Callicott R, Kicman AT. Nandrolone progress report to the UK Sports Council from the Expert Committee on Nandrolone. Int J Sports Med 2003; 24: 620-626.
4. Breidbach A, Catlin DH. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry Rapid Commun Mass Spectrom 2001; 15: 2379-2382.
5. Schumacher OY, Ashenden M. Doping with artificial oxygen carriers: an update. Sports Med 2004; 34: 141-150.
6. Parisotto R, Gore CJ, Emslie KR, et al. A novel method utilising markers of erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologicia 2000; 85: 564-572.

Online responses are no longer available. Please refer to our instructions for authors page for more information.